Full Length Research Paper
References
|
Bayer R, Galea S (2015). Public Health in the Precision-Medicine Era. New England Journal of Medicine, 373:499-501. |
|
|
Bertier J, Jian C, Vassilis R, Yann J (2016). Integrating precision cancer medicine into healthcare- policy, practice, and research challenges. Genome Medicine, 8(1):108. |
|
|
Bierut LJ, Johnson EO, Saccone NL (2014). A glimpse into the future- personalized medicine for smoking cessation. Neuropharmacology, 76Pt B:592-599. |
|
|
Downing GJ (2009). Key aspects of health system change on the path to personalized medicine. Translational Research, 154(6):272-276. |
|
|
Dzau VJ, Ginsburg GS, Chopra A, Goldman D, Green ED, Leonard DGB, McClellan M, Plump A, Terry SF, Yamamoto KR (2016). Realizing the full potential of precision medicine in health and health care. National Academy of Medicine,13 p. |
|
|
Feero WG (2017). Introducing "genomics and precision health". JAMA, 317(18):1842-1843. |
|
|
Ferkol T, Quinton P (2015). Precision Medicine: At What Price? Am. J. Respiratory Crit. Care Medicine, 192(6):658-659 |
|
|
Hanash S, Taguchi A (2011). Application of proteomics to cancer early detection. Cancer Journal, 17(6):423-428. |
|
|
Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, Dannenberg AJ, Hait WN, Blackburn E, Davidson NE, Foti M, Lippman SM (2016). Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prevention Research, (Phila) 9(1):2-10. |
|
|
Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St Pierre J (2011). Current priorities for public health practice in addressing the role of human genomics in improving population health. American Journal of Preventive Medicine, 40(4):486-493. |
|
|
Khoury MJ, Gwinn M, Glasgow RE, Kramer BS (2012). A population perspective on how personalized medicine can improve health American Journal of Preventive Medicine, 42(6):639-645. |
|
|
Khoury MJ, Iademarco MF, Riley WT (2016). Precision public health for the era of precision medicine. American Journal of Preventive Medicine, 50(3):398-401. |
|
|
Mach H (2017). How Stanford health care is bringing precision medicine into preventive primary care. Available at: View. |
|
|
Manamperi A (2008). Current developments in genomics and personalized health care: impact on public health. Asia-Pacific Journal of Public Health, 20(3):242-250. |
|
|
McEwen BS, Getz L (2013).Lifetime experiences, the brain and personalized medicine: an integrative perspective. Metabolism 62(Suppl 1):S20-S26. |
|
|
National Institutes of Health (2018). All of us research program. Available at: https://allofus.nih.gov/about/about-all-us-research-program. |
|
|
Phillips CM (2016). Metabolically healthy obesity: personalised and public health implications. Trends Endocrinology Metabolism, (4):189-191. |
|
|
Roman S, Panduro A (2015). Genomic medicine in gastroenterology: a new approach or a new speciality? World Journal of Gastroenterology, 21(27):8227-8237. |
|
|
Spiegel AM, Hawkins M (2012). Personalized medicine to identify genetic risks for type 2 diabetes and focus prevention: can it fulfill its promise? Health Affairs. (Millwood), 31(1):43-49. |
|
|
U.S. National Library of Medicine (2017). Help me understand genetics precision medicine. Available at: View. |
|
|
Vaithinathan AG, Vanitha A (2017). Public health and precision medicine share a common goal. Journal of Evidence-Based Medicine, 10(2):76-80. |
|
|
Vargas AJ, Harris CC (2016). Biomarker development in the precision medicine era: lung cancer as a case study. Nature Reviews Cancer, 16:525-537. |
|
|
Vazquez AI, de los Campos G, Klimentidis YC, Rosa GJ, Gianola D, Yi N, Allison DB (2012). A comprehensive genetic approach for improving prediction of skin cancer risk in humans. Genetics, 192(4):1493-1502. |
|
|
Whittemore R, Knafl K (2005). The integrative review: updated methodology. Journal of Advanced Nursing, 52:546-553. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
